385 related articles for article (PubMed ID: 30413742)
1. High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon.
Matsuda M; Yamanaka A; Yato K; Yoshii K; Watashi K; Aizaki H; Konishi E; Takasaki T; Kato T; Muramatsu M; Wakita T; Suzuki R
Sci Rep; 2018 Nov; 8(1):16624. PubMed ID: 30413742
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
Yamanaka A; Suzuki R; Konishi E
Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
[TBL] [Abstract][Full Text] [Related]
4. Utility of Japanese encephalitis virus subgenomic replicon-based single-round infectious particles as antigens in neutralization tests for Zika virus and three other flaviviruses.
Yamanaka A; Moi ML; Takasaki T; Kurane I; Matsuda M; Suzuki R; Konishi E
J Virol Methods; 2017 May; 243():164-171. PubMed ID: 28219763
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles.
Lücke AC; Vom Hemdt A; Wieseler J; Fischer C; Feldmann M; Rothenfusser S; Drexler JF; Kümmerer BM
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215941
[TBL] [Abstract][Full Text] [Related]
6. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
[TBL] [Abstract][Full Text] [Related]
7. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
10. Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon.
Suzuki R; Ishikawa T; Konishi E; Matsuda M; Watashi K; Aizaki H; Takasaki T; Wakita T
J Gen Virol; 2014 Jan; 95(Pt 1):60-65. PubMed ID: 24096319
[TBL] [Abstract][Full Text] [Related]
11. Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections.
Stiasny K; Malafa S; Aberle SW; Medits I; Tsouchnikas G; Aberle JH; Holzmann H; Heinz FX
Viruses; 2021 Mar; 13(4):. PubMed ID: 33807442
[TBL] [Abstract][Full Text] [Related]
12. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.
Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R
Virol J; 2019 May; 16(1):65. PubMed ID: 31101058
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
[TBL] [Abstract][Full Text] [Related]
14. [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey].
Tezcan S; Kızıldamar S; Ulger M; Aslan G; Tiftik N; Ozkul A; Emekdaş G; Niedrig M; Ergünay K
Mikrobiyol Bul; 2014 Oct; 48(4):606-17. PubMed ID: 25492656
[TBL] [Abstract][Full Text] [Related]
15. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ
PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605
[TBL] [Abstract][Full Text] [Related]
16. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins.
Merbah M; Wollen-Roberts S; Shubin Z; Li Y; Bai H; Dussupt V; Mendez-Rivera L; Slike B; Krebs SJ; Modjarrad K; Michael NL; Rolland M
J Immunol Methods; 2020 Dec; 487():112874. PubMed ID: 33022219
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
[TBL] [Abstract][Full Text] [Related]
19. Identifying optimal capsid duplication length for the stability of reporter flaviviruses.
Baker C; Liu Y; Zou J; Muruato A; Xie X; Shi PY
Emerg Microbes Infect; 2020 Dec; 9(1):2256-2265. PubMed ID: 32981479
[No Abstract] [Full Text] [Related]
20. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
